Liaoning Chengda Biotechnology Co (SHSE:688739) ROCE %: 0.06% (As of Mar. 2026)


SHSE:688739 Liaoning Chengda Biotechnology Co Ltd SHSE:688739
69 GF Score
Price ¥19.65
GF Value ¥22.14
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Liaoning Chengda Biotechnology Co ROCE %?

Liaoning Chengda Biotechnology Co SHSE:688739 -3.34% 69 ROCE % is 0.06% as of Mar. 2026. GuruFocus rates SHSE:688739 with a GF Score™ of 69/100 and a GF Value™ of ¥22.14 (Modestly Undervalued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Liaoning Chengda Biotechnology Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 0.06%.

Liaoning Chengda Biotechnology Co  (SHSE:688739) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Liaoning Chengda Biotechnology Co ROCE % Related Terms

Liaoning Chengda Biotechnology Co ROCE % Historical Data

* Premium members only.

The historical data trend for Liaoning Chengda Biotechnology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Liaoning Chengda Biotechnology Co ROCE % Chart

Liaoning Chengda Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.99 8.70 5.92 4.17 1.79

Liaoning Chengda Biotechnology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.31 2.75 2.76 -1.72 0.06
SHSE:688739
69GF Score
Liaoning Chengda Biotechnology Co Ltd SHSE:688739
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Liaoning Chengda Biotechnology Co ROCE % Calculation

Liaoning Chengda Biotechnology Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=171.031/( ( (10051.587 - 393.307) + (9746.208 - 300.634) )/ 2 )
=171.031/( (9658.28+9445.574)/ 2 )
=171.031/9551.927
=1.79 %

Liaoning Chengda Biotechnology Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=5.368/( ( (9746.208 - 300.634) + (9675.551 - 236.495) )/ 2 )
=5.368/( ( 9445.574 + 9439.056 )/ 2 )
=5.368/9442.315
=0.06 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.06% mean?
Liaoning Chengda Biotechnology Co (SHSE:688739) has a ROCE % of 0.06% as of Mar. 2026.
Is Liaoning Chengda Biotechnology Co's ROCE % too high?
Liaoning Chengda Biotechnology Co's current ROCE % is 0.06%. Overall, Liaoning Chengda Biotechnology Co has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Liaoning Chengda Biotechnology Co's ROCE % compare to VRTX and REGN?
Liaoning Chengda Biotechnology Co's ROCE % of 0.06% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Liaoning Chengda Biotechnology Co's current ROCE % is 0.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liaoning Chengda Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Liaoning Chengda Biotechnology Co (SHSE:688739) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥22.14, compared to a current price of ¥19.65 — trading 11.2% below its estimated fair value. The current ROCE % is 0.06%. Liaoning Chengda Biotechnology Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Liaoning Chengda Biotechnology Co (SHSE:688739), the current ROCE % is 0.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Liaoning Chengda Biotechnology Co (SHSE:688739) Overvalued in 2026?

Based on GuruFocus' analysis, Liaoning Chengda Biotechnology Co stock appears to be undervalued. The current stock price of ¥19.65 is trading 11.2% below its estimated GF Value™ of ¥22.14. GuruFocus considers Liaoning Chengda Biotechnology Co to be Modestly Undervalued.

Key valuation signals for SHSE:688739:

  • ROCE %: 0.06%
  • GF Value™: ¥22.14 vs. price of ¥19.65 (11.2% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Liaoning Chengda Biotechnology Co Business Description

Address No. 1, Xinfang Street, Hunnan New District, Liaoning Province, Shenyang, CHN, 110179
Liaoning Chengda Biotechnology Co Ltd is engaged in the research and development, production and sales of human vaccines.
69GF Score

Get the complete analysis for SHSE:688739

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥19.65
Price
¥22.14
GF Value